Clinical Trials Browser

Phase 2 × Leukemia, Myelomonocytic, Acute × Arsenic Trioxide × Clear all

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT00005795 2012-06-11

Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia

Phase 2 Completed

11 enrolled

Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Clinical Trials

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia